Cabio Biotech (Wuhan) Co (SHSE:688089) 3-Year Book Growth Rate : 3.80% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co 3-Year Book Growth Rate?

Cabio Biotech (Wuhan) Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥8.92.

During the past 12 months, Cabio Biotech (Wuhan) Co's average Book Value per Share Growth Rate was 4.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 3.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Cabio Biotech (Wuhan) Co was 32.40% per year. The lowest was 3.80% per year. And the median was 19.45% per year.

Competitive Comparison of Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate falls into.

Cabio Biotech (Wuhan) Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Cabio Biotech (Wuhan) Co (SHSE:688089) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Cabio Biotech (Wuhan) Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073

Website

http://www.cabio.cn

Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.

Executives

Shang Yun	Core technical personnel
Wang Hua Biao	Directors, senior managers
Geng An Feng	senior management
Du Bin	Director
Yi Hua Rong	senior management
Ma Tao	senior management
Li Xiang Yu	senior management
Wu Yu Jun	Supervisors
Xiao Min	senior management
Wang Zhi Ming	senior management
Lu Shu Huan	Core technical personnel
Yi De Wei	Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines